Related references
Note: Only part of the references are listed.Attenuation of Vaccinia Tian Tan Strain by Removal of Viral TC7L-TK2L and TA35R Genes
Shifu Kan et al.
PLOS ONE (2012)
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Lilin Lai et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
Kristina E. Rehm et al.
VACCINE (2011)
Establishment of a Cre/loxP recombination system for N-terminal epitope tagging of genes in Tetrahymena
Clara Jana-Lui Busch et al.
BMC MICROBIOLOGY (2010)
New Strategy of Functional Analysis of PHGPx Knockout Mice Model Using Transgenic Rescue Method and Cre-LoxP System
Hirotaka Imai
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2010)
One time intranasal vaccination with a modified vaccinia Tiantan strain MVTTZCI protects animals against pathogenic viral challenge
Wenbo Yu et al.
VACCINE (2010)
Vaccinia Virus-Encoded Ribonucleotide Reductase Subunits Are Differentially Required for Replication and Pathogenesis
Don B. Gammon et al.
PLOS PATHOGENS (2010)
A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
Xiaoxing Huang et al.
PLOS ONE (2009)
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge
Aklile Berhanu et al.
JOURNAL OF VIROLOGY (2008)
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
Kaifan Dai et al.
VACCINE (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes
Weijun Zhu et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Antibody responses to vaccinia membrane proteins after smallpox vaccination
Steven J. Lawrence et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Vaccinia virus proteome: Identification of proteins in vaccinia virus intracellular mature virion particles
CS Chung et al.
JOURNAL OF VIROLOGY (2006)
Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain
Q Fang et al.
VIROLOGY (2005)
Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice
CS Branda et al.
DEVELOPMENTAL CELL (2004)
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
I Drexler et al.
CURRENT OPINION IN BIOTECHNOLOGY (2004)
IL-12 and IL-18 act in synergy to clear vaccinia virus infection:: involvement of innate and adaptive components of the immune system
MM Gherardi et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells
A Domi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Vaccinia virus blocks gamma interferon signal transduction: Viral VH1 phosphatase reverses Stat1 activation
P Najarro et al.
JOURNAL OF VIROLOGY (2001)
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence
WH Zhang et al.
JOURNAL OF VIROLOGY (2000)
The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses
T Betakova et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
